Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What Growth Rate is the Angina Pectoris Drugs Market Anticipated to Experience from 2024-2033?

In the past few years, the market size for angina pectoris drugs has seen strong growth. It’s projected to develop from $11.82 billion in 2023 to $12.47 billion in 2024, with a compound annual growth rate (CAGR) of 5.5%. The historic growth can be associated with the higher prevalence of cardiovascular diseases, senior population demographics, lifestyle-related factors, surge in hypertension rates and the prevalence of diabetes.

The market size for drugs treating angina pectoris is projected to experience substantial growth in the upcoming years, expected to reach a value of $15.48 billion in 2028, with a compound annual growth rate (CAGR) of 5.6%. The expansion during the forecasted period is due to factors such as the increasing global rates of obesity, advancements in precision medicine, the emphasis on preventive cardiology, initiatives educating patients, and research on innovative treatment options. Key trends within this period will include the use of telemedicine for distant monitoring, studies on real-world evidence and outcomes, patient-focused medical education, strategic collaborations for market accessibility, and advancements in regulatory processes as well as accelerated approvals.

Claim Your Free Sample of the Global Angina Pectoris Drugs Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=10797&type=smp

What Are the Significant Influencers of Growth in the angina pectoris drugs Market?

The rise in chronic angina pectoris occurrences is anticipated to stimulate the expansion of the angina pectoris drug market. Chronic angina pectoris is a condition characterized by chest pain or discomfort due to insufficient blood supply to the heart muscles. Medications for angina pectoris are crucial for managing chronic angina and offer various advantages for those affected by this condition, such as coronary heart disease, cardiovascular disease, hypertension, and being overweight or obese. For example, in May 2023, the Centers for Disease Control and Prevention Highlights, a US government agency, stated that coronary heart disease was responsible for approximately 375,476 deaths in 2021, accounting for nearly 5% of individuals aged 20 and older. Furthermore, in 2021, nearly two out of every ten fatalities from coronary artery disease were predicted to happen in individuals under the age of 65. Additionally, in December 2022, data from the National Library of Medicine, a national biological information center, revealed that Angina impacts over 10 million individuals in the United States, with over 500,000 new cases diagnosed annually. Hence, the rising prevalence of chronic angina pectoris is fueling the expansion of the angina pectoris drug market.

What Key Segments Define the Angina Pectoris Drugs Market?

1) By Drugs: Nitrates, Antiplatelet Agents, Beta-adrenergic Blocking Agents, Calcium Channel Blockers, Anti-ischemic Agents, Statins, Antihypertensive Agents, Other Drugs

2) By Indication: Stable Angina, Unstable Angina, Prinzmetal’s Angina

3) By Route of Administration: Oral, Parenteral, Transdermal, Other Route Of Administrations

4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

What Are the Key Developments Shaping the Angina Pectoris Drugs Market?

A significant trend emerging in the angina pectoris medications market is product innovation. To maintain their market position, prominent companies in this industry are embracing new technologies. In an example from March 2023, Hikma Pharmaceuticals plc, a pharmaceutical firm based in the UK, introduced Labetalol Hydrochloride Injection, USP, in a prefilled syringe. This product has received approval from the US Food and Drug Administration. Hospitals often use the 10 mg/2 mL PFS to manage severe hypertension and reduce blood pressure.

Order Now for Fast Delivery of Your Angina Pectoris Drugs Market Report!

https://www.thebusinessresearchcompany.com/report/angina-pectoris-drugs-global-market-report

What Regions Are Driving Expansion in the Angina Pectoris Drugs Market?

North America was the largest region in the angina pectoris drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina pectoris drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Angina Pectoris Drugs Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the angina pectoris drugs market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Angina Pectoris Drugs Market Include

1. Angina Pectoris Drugs Market Executive Summary

2. Angina Pectoris Drugs Market Segments

3. Angina Pectoris Drugs Market Size And Template Market Growth Rate

4. Key Angina Pectoris Drugs Market Trends

5. Major Angina Pectoris Drugs Market Drivers

……

25. Key Mergers And Acquisitions In The Angina Pectoris Drugs Market

26. Top Angina Pectoris Drugs Companies

27. Angina Pectoris Drugs Market Opportunities And Strategies

28. Angina Pectoris Drugs Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Alzheimer’s Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/alzheimers-drugs-global-market-report

Osteoporosis Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/osteoporosis-drugs-global-market-report

Muscle Relaxant Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/muscle-relaxant-drugs-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: